C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α

Oncogene

Volumn 30, Issue 49, 2011, Pages 4901-4909

  Min, Y ^a   Ghose, S ^b   Boelte, K ^c   Li, J ^b   Yang, L ^a   Lin, P C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C EBP d; HIF 1a; lymphangiogenesis; metastasis; VEGF C

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; HYPOXIA INDUCIBLE FACTOR 1; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BONE MARROW; CELL CULTURE; CELL MOTILITY; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUNG CANCER; LUNG METASTASIS; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; NULL ALLELE; PARACRINE SIGNALING; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; AUTOCRINE COMMUNICATION; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL HYPOXIA; CELL LINE, TUMOR; ENDOTHELIAL CELLS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG NEOPLASMS; LYMPHANGIOGENESIS; MICE; NEOPLASM METASTASIS; SUBSTRATE SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

MUS;

EID: 82955163263     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.187     Document Type: Article

References (35)

1. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y et al. (2000). Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 83: 887-891.
2. Alitalo K, Carmeliet P. (2002). Molecular mechanisms of lymphan-giogenesis in health and disease. Cancer Cell 1: 219-227. (Pubitemid 41039145)
3. Alitalo K, Tammela T, Petrova TV. (2005). Lymphangiogenesis in development and human disease. Nature 438: 946-953. (Pubitemid 43093960)
4. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K et al. (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949. (Pubitemid 28507528)
5. He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T et al. (2002). Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825. (Pubitemid 34705053)
6. Helotera H, Alitalo K. (2007). The VEGF family, the inside story. Cell 130: 591-592. (Pubitemid 47268069)
7. Irigoyen M, Anso E, Martinez E, Garayoa M, Martinez-Irujo JJ, Rouzaut A. (2007). Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 1773: 880-890. (Pubitemid 46829434)
8. Johnson PF. (2005). Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. J Cell Sci 118: 2545-2555. (Pubitemid 40932881)
9. Kamiyama M, Pozzi A, Yang L, DeBusk LM, Breyer RM, Lin PC. (2006). EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival. Oncogene 25: 7019-7028. (Pubitemid 44722070)
10. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV et al. (2004). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80. (Pubitemid 38081471)
11. Katsuta M, Miyashita M, Makino H, Nomura T, Shinji S, Yamashita K et al. (2005). Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer. Exp Mol Pathol 78: 123-130. (Pubitemid 40248793)
12. Kim Y, Fischer SM. (1998). Transcriptional regulation of cycloox-ygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues. J Biol Chem 273: 27686-27694. (Pubitemid 28500494)
13. Kitami Y, Fukuoka T, Hiwada K, Inagami T. (1999). A high level of CCAAT-enhancer binding protein-delta expression is a majordeterminant for markedly elevated differential gene expression of the platelet-derived growth factor-alpha receptor in vascular smooth muscle cells of genetically hypertensive rats. Circ Res 84: 64-73. (Pubitemid 29074881)
14. Kurokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y et al. (2003). Overexpression of hypoxia-inducible-factor 1alpha(-HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 89: 1042-1047. (Pubitemid 37239209)
15. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E et al. (2003). Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105: 176-181. (Pubitemid 36505317)
16. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S et al. (2007). Autocrine VEGF signaling is required for vascular home-ostasis. Cell 130: 691-703. (Pubitemid 47268059)
17. Makinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC et al. (2001). Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20: 4762-4773. (Pubitemid 32848629)
18. Milde-Langosch K, Loning T, Bamberger AM. (2003). Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopatholo-gic parameters and cell-cycle regulatory proteins. Breast Cancer Res Treat 79: 175-185. (Pubitemid 36649167)
19. Ota H, Katsube K, Ogawa J, Yanagishita M. (2007). Hypoxia/Notch signaling in primary culture of rat lymphatic endothelial cells. FEBS Lett 581: 5220-5226. (Pubitemid 350018748)
20. Poli V. (1998). The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273: 29279-29282. (Pubitemid 28509923)
21. Rabek JP, Scott S, Hsieh CC, Reisner PD, Papaconstantinou J. (1998). Regulation of LPS-mediated induction of C/EBP delta gene expression in livers of young and aged mice. Biochim Biophys Acta 1398: 137-147. (Pubitemid 28305207)
22. Ramji DP, Foka P. (2002). CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 365: 561-575. (Pubitemid 34864439)
23. Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M et al. (2006). Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 99: 135-141. (Pubitemid 44268261)
24. Semenza GL. (1998). Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr Opin Genet Dev 8: 588-594. (Pubitemid 28477364)
25. Simiantonaki N, Jayasinghe C, Michel-Schmidt R, Peters K, Hermanns MI, Kirkpatrick CJ. (2008). Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines. Int J Oncol 32: 585-592. (Pubitemid 351330464)
26. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P et al. (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198. (Pubitemid 32148486)
27. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. (2002). Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2: 573-583. (Pubitemid 37328924)
28. Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, Tessarollo L et al. (1998). Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci USA 95: 10908-10913. (Pubitemid 28413167)
29. Takata Y, Kitami Y, Yang ZH, Nakamura M, Okura T, Hiwada K. (2002). Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma. Circ Res 91: 427-433. (Pubitemid 35034211)
30. Tanaka T, Yoshida N, Kishimoto T, Akira S. (1997). Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 16: 7432-7443. (Pubitemid 28010503)
31. Tang N, Wang L, Esko J, Giordano FJ, Huang Y, Gerber HP et al. (2004). Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 6: 485-495. (Pubitemid 39469984)
32. Tang Y, Pacary E, Freret T, Divoux D, Petit E, Schumann-Bard P et al. (2006). Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke. Neurobiol Dis 21: 18-28. (Pubitemid 41817301)
33. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, Hennighausen L et al. (2005). C/EBPdelta is a crucial regulator of proapoptotic gene expression during mammary gland involution. Development 132: 4675-4685. (Pubitemid 41685278)
34. Yang ZH, Kitami Y, Takata Y, Okura T, Hiwada K. (2001). Targeted overexpression of CCAAT/enhancer-binding protein-delta evokes enhanced gene transcription of platelet-derived growth factor alpha-receptor in vascular smooth muscle cells. Circ Res 89: 503-508. (Pubitemid 34132644)
35. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E et al. (1999). Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5: 1823-1829. (Pubitemid 29334464)